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Hereditary portion as an 
initial genetic approach 
in gynecologic cancer: 
synchronous tumor of 
ovary and endometrium
To the editor: Hereditary portion and genetic status are very 
important to work out strategies for cancer prevention and 
early detection in gynecologic cancers. Familial history of re-
lated cancers within the second degree relatives are approxi-
mately 10% and 20% in endometrial cancer and ovarian can-
cer, respectively [1,2]. The proportion of genetic background 
and germline mutation in Korean women with gynecologic 
cancer is comparable to those of western ethnics [1,2].
Two interesting articles dealing synchronous cancers of 
endometrium and ovary appeared in the December issue 
[3,4]. The 5-year overall survival of women with synchronous 
cancers of endometrium and ovary was 78% from Singapore 
[3]. The majority of them were at early stage (83% and 83% 
for endometrial and ovarian cancer, respectively). The rate of 
recurrence was 13.6% (6/46). The site of recurrence could be 
depicted in detail to understand the course of synchronous 
cancers of endometrium and ovary.
Kim et al. [4] reported 32 synchronous tumors of endome-
trium and ovary treated between 1995 and 2001 of Samsung 
Medical Center. Of 32 patients, 9 patients (28%) have a family 
history of cancer. In table 4, lung cancer, pancreatic cancer, 
or stomach cancer was included. Related to hereditary non-
polyposis colorectal cancer (HNPCC), Amsterdam criteria II or 
revised criteria of suspected HNPCC was used. The criteria for 
familial history used in the study should be clearly specified. 
Therefore, definitive incidence of HNPCC using clinical criteria 
could be clearly depicted.
The proportion of both endometrioid adenocarcinoma in 
endometrium and ovary were 50% (18/36) and 74% (34/46) 
from Korea and Singapore, respectively [3,4]. The authors from 
two studies could reveal the proportion of synchronous tumor 
from metachronous tumor among both endometriod histol-
ogy in endometrium and ovary from cancer registry of endo-
metrial cancer and ovarian cancer, respectively. Clarifying the 
proportion of synchronous tumor of endometrium and ovary 
is the beginning of the basic research and clinical application 
of hereditary gynecologic cancer.
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In reply: We thank Dr. Yoo, Park, and Lim for their sincere 
interest in our study and comments. We know diagnostic ap-
proach for Lynch syndrome should be based on Amsterdam 
criteria. At the same time, selecting suitable patients using 
Amsterdam criteria has been reported to be associated with 
high false negative rate [1]. In our algorithm based on im-
munohistochemical analysis and family history, we defined 
‘high-risk family history’ as patients who have at least one 
first-degree relative cancer patient according to medical re-
cord and telephone interview. This family history was used as 
adjunctive criteria to immunohistochemical analysis (MLH1, 
MSH2, and MSH6) in our study. 
Our selection process started with finding simultaneous or 
double primary (multiple) gynecologic malignancy through 
medical chart searching not using total ovary and endome-
trial cancer registry patients. Therefore we cannot show exact 
data right now about “proportion of synchronous tumor from 
metachronous tumor among both endometrioid histology 
in endometrium and ovary”. However, it is certain that meta-
chronous tumor of endometrioid carcinoma in the ovary and 
endometrium may be very rare because most of primary sur-
gery of both endometrial cancer and ovarian cancer include 
hysterectomy and bilateral salphingo-oophorectomy. In ad-
dition, synchronous tumors in the ovary and endometrium 
are also not common. In one study, among 5,366 ovarian car-
cinoma patients, there were 460 with endometrioid subtype 
patients. In addition, among 460 patients, 11.5% (40/460) has 
been investigated to have a same endometrioid type endo-
metrioid carcinoma [2].
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